YPEL4

YPEL4 is a Yippee-domain protein that functions in ERK/MAPK signaling, cell proliferation, and red blood cell membrane integrity. It activates Elk-1 in the MAPK/ERK pathway, an activity inhibited by its physical interaction with the major vault protein (MVP), as demonstrated by multiple orthogonal biochemical assays (PMID:20555386). Overexpression of YPEL4 in adrenocortical cells stimulates proliferation and basal aldosterone production (PMID:27333825). Loss of Ypel4 in mice causes ovalocytic red blood cell morphology, reduced deformability, increased RBC clearance, and decreased Band 3 membrane protein levels, establishing an intrinsic role in maintaining erythrocyte membrane structure (PMID:34354145).

1. 2010 High

   The discovery that YPEL4 physically interacts with MVP and that MVP suppresses YPEL4-mediated Elk-1 activation established YPEL4 as a signaling-active protein regulated by vault-associated mechanisms, placing it within the MAPK/ERK pathway.

   Evidence Yeast two-hybrid, GST pull-down, co-immunoprecipitation, mammalian two-hybrid, and Elk-1 reporter assays in mammalian cells

   PMID:20555386

   Open questions at the time

   • Whether YPEL4 directly activates upstream kinases or acts at the level of Elk-1 itself is unknown
   • The structural basis of the YPEL4–MVP interaction has not been resolved
   • Whether endogenous MVP regulation of YPEL4 occurs in physiological contexts is untested
2. 2016 Medium

   Demonstrating that YPEL4 overexpression promotes adrenocortical cell proliferation and aldosterone secretion linked its signaling activity to a specific endocrine cellular context.

   Evidence Overexpression in HAC15 adrenocortical cells with XTT assay, crystal violet staining, and aldosterone measurement

   PMID:27333825

   Open questions at the time

   • Loss-of-function experiments in adrenal cells have not been performed
   • Whether the proliferative effect depends on the MAPK/ERK–Elk-1 axis identified earlier is untested
   • The mechanism by which YPEL4 enhances aldosterone production is unknown
3. 2021 High

   Knockout mouse studies revealed an unanticipated, cell-intrinsic requirement for YPEL4 in erythrocyte membrane integrity, showing that its loss causes ovalocytosis, reduced deformability, and diminished Band 3 levels — broadening its known biology beyond signaling.

   Evidence Ypel4-null mouse model analyzed by scanning electron microscopy, RBC deformability assays, membrane protein quantification, and in vivo clearance assays

   PMID:34354145

   Open questions at the time

   • No direct physical interaction between YPEL4 and Band 3 was detected; the mechanism by which YPEL4 maintains Band 3 levels is unknown
   • Whether YPEL4 acts during erythropoiesis or in mature RBCs has not been determined
   • Human genetic evidence linking YPEL4 mutations to hereditary ovalocytosis is lacking

• How YPEL4's Yippee/zinc-finger-like domain contributes to its molecular activity — whether enzymatic, scaffolding, or otherwise — remains unresolved, and the relationship between its MAPK signaling role and its erythrocyte membrane function is unknown.
• No enzymatic activity or substrate has been identified for YPEL4
• No structural model of YPEL4 exists
• The connection between MAPK/ERK signaling activity and RBC membrane maintenance has not been investigated